Article
The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Eye (London, England) - 1 Aug 2003
Dodson P M, Haynes J, Starczynski J, Farmer J, Shigdar S, Fegan G, Johnson R J, Fegan C
Abstract excerpt
Retinal vein occlusion (RVO) is associated with hyperhomocysteinaemia and the antiphospholipid syndrome-disorders known to contribute to both arterial and venous thrombosis. In both of these conditions and RVO, platelet activation occurs. Aspirin, not warfarin, is the most effective antithrombotic agent in RVO and, taken together, these observations suggest an important role for platelets in this common ocular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
